Cholestasis Latest Advances

Obeticholic acid: discovery, clinical translation, and regulatory withdrawal.

Journal: European review for medical and pharmacological sciences

Published: October 30, 2026

Genetic and Familial Forms of Pediatric Intrahepatic Cholestasis.

Journal: Clinics in liver disease

Published: October 27, 2026

Implementing Therapeutic Endoscopic Retrograde Cholangiopancreatography in a Resource-Limited Setting: Lessons from the First Completely Minimally Invasive Management of Choledocholithiasis in Benin Republic.

Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A

Published: October 27, 2026

Artificial Intelligence-Assisted Peroral Cholangioscopy for the Diagnosis and Management of Biliary Strictures: Current Evidence and Future Directions.

Journal: Acta medica Okayama

Published: October 27, 2026

Intrinsic epithelial defects and NF-κB-dependent signaling heighten viral injury in biliary atresia.

Journal: JCI insight

Published: October 27, 2026

Alagille Syndrome: Phenotypes, Genotypes, and Outcomes.

Journal: Clinics in liver disease

Published: October 27, 2026

Bile Acid Synthesis and Metabolism Disorders.

Journal: Clinics in liver disease

Published: October 27, 2026

Intestinal Failure-Associated Liver Disease: Current Understanding and Recent Advances.

Journal: Clinics in liver disease

Published: October 27, 2026

SEFA-6179, an Engineered Medium-Chain Fatty Acid, Prevents Alcoholic Liver Injury and Steatosis in a Murine Model of Alcohol-associated Liver Disease.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: October 26, 2026

Obstructive cholestasis without biliary dilatation from a hepatic cyst.

Journal: BMJ case reports

Published: October 23, 2026

AGA/AASLD Clinical Practice Guideline on Management of Primary Biliary Cholangitis.

Journal: Gastroenterology

Published: October 23, 2026

Biomarkers of subclinical cholestasis predict cancer immunotherapy outcomes.

Journal: Oncoimmunology

Published: October 15, 2026

Cholestasis Latest Advances

Find the Latest Research About Cholestasis

Obeticholic acid: discovery, clinical translation, and regulatory withdrawal.

Obeticholic acid: discovery, clinical translation, and regulatory withdrawal.

Genetic and Familial Forms of Pediatric Intrahepatic Cholestasis.

Genetic and Familial Forms of Pediatric Intrahepatic Cholestasis.

Implementing Therapeutic Endoscopic Retrograde Cholangiopancreatography in a Resource-Limited Setting: Lessons from the First Completely Minimally Invasive Management of Choledocholithiasis in Benin Republic.

Implementing Therapeutic Endoscopic Retrograde Cholangiopancreatography in a Resource-Limited Setting: Lessons from the First Completely Minimally Invasive Management of Choledocholithiasis in Benin Republic.

Artificial Intelligence-Assisted Peroral Cholangioscopy for the Diagnosis and Management of Biliary Strictures: Current Evidence and Future Directions.

Artificial Intelligence-Assisted Peroral Cholangioscopy for the Diagnosis and Management of Biliary Strictures: Current Evidence and Future Directions.

Intrinsic epithelial defects and NF-κB-dependent signaling heighten viral injury in biliary atresia.

Intrinsic epithelial defects and NF-κB-dependent signaling heighten viral injury in biliary atresia.

Alagille Syndrome: Phenotypes, Genotypes, and Outcomes.

Alagille Syndrome: Phenotypes, Genotypes, and Outcomes.

Bile Acid Synthesis and Metabolism Disorders.

Bile Acid Synthesis and Metabolism Disorders.

Intestinal Failure-Associated Liver Disease: Current Understanding and Recent Advances.

Intestinal Failure-Associated Liver Disease: Current Understanding and Recent Advances.

SEFA-6179, an Engineered Medium-Chain Fatty Acid, Prevents Alcoholic Liver Injury and Steatosis in a Murine Model of Alcohol-associated Liver Disease.

SEFA-6179, an Engineered Medium-Chain Fatty Acid, Prevents Alcoholic Liver Injury and Steatosis in a Murine Model of Alcohol-associated Liver Disease.

Obstructive cholestasis without biliary dilatation from a hepatic cyst.

Obstructive cholestasis without biliary dilatation from a hepatic cyst.

AGA/AASLD Clinical Practice Guideline on Management of Primary Biliary Cholangitis.

AGA/AASLD Clinical Practice Guideline on Management of Primary Biliary Cholangitis.

Biomarkers of subclinical cholestasis predict cancer immunotherapy outcomes.

Biomarkers of subclinical cholestasis predict cancer immunotherapy outcomes.